Dermata Therapeutics, Inc. ( NASDAQ:DRMA – Get Rating ) saw a large decrease in short interest in April. As of April 15th, there was short interest totalling 18,100 shares, a decrease of 40.8% from the March 31st total of 30,600 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.2% of the shares of the stock are sold short. Institutional Investors Weigh In On Dermata Therapeutics A hedge fund recently bought a new stake in Dermata Therapeutics stock.

https://www.dailypolitical.com/2023/04/27/dermata-therapeutics-inc-nasdaqdrma-short-interest-down-40-8-in-april.html

#dailypolitical